Multi-omics approach reveals CCND1, GABPA, HIF1A, and SOX6 as key regulators and prognostic markers in heart failure

Ping He1,2, Lang Deng3,4, Kaijie Wu5

  • 1Fifth School of Clinical Medicine of Zhejiang, Huzhou Central Hospital, Chinese Medical University, Huzhou, 313000, Zhejiang, China.

Hereditas
|August 16, 2025
PubMed

Insights

This study identifies key genes like CCND1 and HIF1A as potential biomarkers for heart failure (HF). Findings offer insights into HF progression and therapeutic targets for better disease management.

Area of Science:

  • Cardiovascular Biology
  • Molecular Medicine
  • Genomics

Background:

  • Heart failure (HF) is a complex, progressive condition with incompletely understood molecular underpinnings.
  • Identifying novel biomarkers and therapeutic targets is crucial for effective HF management.

Purpose of the Study:

  • To identify differentially expressed genes (DEGs) in heart failure (HF) patients.
  • To explore the roles of key genes (hub genes) in HF pathophysiology.
  • To develop a predictive risk model for HF disease progression and identify potential therapeutic targets.

Main Methods:

  • Analysis of gene expression datasets from human HF and normal cardiomyocyte cell lines.
  • Construction of Protein-Protein Interaction (PPI) networks and analysis of immune cell infiltration.
  • Development of a risk prediction model using LASSO regression and drug screening via CMap.

Main Results:

  • Identified 182 common DEGs in HF, with CCND1, GABPA, HIF1A, and SOX6 as significant hub genes.
  • Established a risk model correlated with HF progression and observed altered immune cell profiles.
  • Overexpression of CCND1 and HIF1A impaired cell proliferation and migration, confirming their role in HF.

Conclusions:

  • CCND1, GABPA, HIF1A, and SOX6 are potential biomarkers for heart failure (HF).
  • Findings illuminate the roles of immune infiltration and miRNA regulation in HF.
  • The study provides insights into novel therapeutic targets for HF management and highlights gene regulation's importance in disease progression.
Abstract

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
41
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.8K
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
214
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
7.0K